The effect of the menopause and hormone replacement therapy on serum carboxyterminal propeptide of type I collagen

This publication has 11 references indexed in Scilit:

• Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
  1992
• Desogestrel in hormone replacement therapy: long‐term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding
  European Journal of Clinical Investigation, 1991
• The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: The effect of nandrolone decanoate and female sex hormones
  Metabolism, 1991
• Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells
  Biochemical Journal, 1990
• Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen
  Clinical Chemistry, 1990
• The pathophysiology of peri‐ and postmenopausal bone loss
  BJOG: An International Journal of Obstetrics and Gynaecology, 1989
• Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphatase
  Journal of Bone and Mineral Research, 1987
• CYPROTERONE ACETATE, AN ALTERNATIVE GESTAGEN IN POSTMENOPAUSAL OESTROGEN/GESTAGEN THERAPY
  Clinical Endocrinology, 1987
• Metabolic consequences of the menopause. A cross-sectional, longitudinal, and intervention study on 557 normal postmenopausal women.
  1987
• The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss
  American Journal of Obstetrics and Gynecology, 1987